HRP20182066T1 - Novi derivati 4-metoksi pirola ili njihove soli i farmaceutski pripravak koji ih sadrži - Google Patents
Novi derivati 4-metoksi pirola ili njihove soli i farmaceutski pripravak koji ih sadržiInfo
- Publication number
- HRP20182066T1 HRP20182066T1 HRP20182066TT HRP20182066T HRP20182066T1 HR P20182066 T1 HRP20182066 T1 HR P20182066T1 HR P20182066T T HRP20182066T T HR P20182066TT HR P20182066 T HRP20182066 T HR P20182066T HR P20182066 T1 HRP20182066 T1 HR P20182066T1
- Authority
- HR
- Croatia
- Prior art keywords
- salts
- novel
- pharmaceutical composition
- same
- pyrrole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150058712 | 2015-04-27 | ||
| KR1020160013588A KR101613245B1 (ko) | 2015-04-27 | 2016-02-03 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| EP16786741.5A EP3197867B1 (en) | 2015-04-27 | 2016-04-27 | Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same |
| PCT/KR2016/004411 WO2016175555A2 (en) | 2015-04-27 | 2016-04-27 | Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20182066T1 true HRP20182066T1 (hr) | 2019-02-08 |
Family
ID=55916928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20182066TT HRP20182066T1 (hr) | 2015-04-27 | 2018-12-06 | Novi derivati 4-metoksi pirola ili njihove soli i farmaceutski pripravak koji ih sadrži |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US10100010B1 (hr) |
| EP (1) | EP3197867B1 (hr) |
| JP (1) | JP6244498B1 (hr) |
| KR (2) | KR101613245B1 (hr) |
| CN (1) | CN107001263B (hr) |
| AU (1) | AU2016255308B2 (hr) |
| CA (1) | CA2977750C (hr) |
| CL (1) | CL2017002571A1 (hr) |
| CO (1) | CO2017010539A2 (hr) |
| DO (2) | DOP2017000230A (hr) |
| EC (1) | ECSP17071036A (hr) |
| ES (1) | ES2703709T3 (hr) |
| HR (1) | HRP20182066T1 (hr) |
| HU (1) | HUE042449T2 (hr) |
| MA (1) | MA40887B1 (hr) |
| MX (1) | MX2017012507A (hr) |
| MY (1) | MY193257A (hr) |
| NZ (1) | NZ734896A (hr) |
| PE (1) | PE20180022A1 (hr) |
| PH (1) | PH12017501755A1 (hr) |
| PL (1) | PL3197867T3 (hr) |
| PT (1) | PT3197867T (hr) |
| RS (1) | RS58076B1 (hr) |
| RU (1) | RU2663895C1 (hr) |
| SA (1) | SA517390127B1 (hr) |
| SG (1) | SG11201706877RA (hr) |
| SI (1) | SI3197867T1 (hr) |
| TN (1) | TN2017000424A1 (hr) |
| WO (1) | WO2016175555A2 (hr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
| KR20170113040A (ko) * | 2016-03-25 | 2017-10-12 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염 |
| WO2017164575A1 (en) * | 2016-03-25 | 2017-09-28 | Daewoong Pharmaceutical Co.,Ltd. | Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine |
| KR102233456B1 (ko) * | 2017-05-31 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| KR102233455B1 (ko) * | 2017-06-21 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| KR102126576B1 (ko) * | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| WO2020060213A1 (ko) | 2018-09-19 | 2020-03-26 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| CN114845701A (zh) * | 2019-12-18 | 2022-08-02 | 株式会社大熊制药 | 1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺酰基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺的液体药物组合物 |
| WO2021256861A1 (ko) | 2020-06-17 | 2021-12-23 | 일동제약(주) | 신규한 산 분비 억제제 및 이의 용도 |
| CN112094219B (zh) * | 2020-09-10 | 2022-08-05 | 广东莱佛士制药技术有限公司 | 一种制备钾离子竞争性阻滞剂中间体的方法 |
| WO2022051979A1 (zh) * | 2020-09-10 | 2022-03-17 | 广东莱佛士制药技术有限公司 | 一种制备钾离子竞争性阻滞剂中间体的方法 |
| TW202241409A (zh) | 2020-12-18 | 2022-11-01 | 南韓商大熊製藥股份有限公司 | 包含1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺醯基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺之用於經口投予的新調配物 |
| CA3217204A1 (en) | 2021-05-26 | 2022-12-01 | Daewoong Pharmaceutical Co., Ltd. | New formulation for injection comprising 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine |
| CA3218713A1 (en) | 2021-05-26 | 2022-12-01 | Daewoong Pharmaceutical Co., Ltd. | Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine |
| KR102556500B1 (ko) | 2021-11-19 | 2023-07-19 | 하나제약 주식회사 | 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물 |
| KR20230091066A (ko) * | 2021-12-15 | 2023-06-22 | 주식회사 대웅제약 | 펙수프라잔 주사제 조성물 용법용량 |
| WO2023113474A1 (ko) * | 2021-12-15 | 2023-06-22 | 일동제약(주) | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20230091056A (ko) * | 2021-12-15 | 2023-06-22 | 일동제약(주) | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20230102353A (ko) * | 2021-12-30 | 2023-07-07 | 주식회사 대웅제약 | 삼중음성유방암의 예방 또는 치료용 약학적 조성물 |
| WO2023211843A1 (en) * | 2022-04-25 | 2023-11-02 | Daewoong Pharmaceutical Co., Ltd. | Potassium-competitive acid blockers for the treatment of pathological hypersecretory conditions |
| WO2023229323A1 (ko) * | 2022-05-23 | 2023-11-30 | 일동제약(주) | 6-메톡시피리딘-3-일 유도체의 제조방법 |
| WO2023229322A1 (ko) * | 2022-05-23 | 2023-11-30 | 일동제약(주) | 6-메톡시피리딘-3-일 유도체의 제조방법 |
| CN117820193A (zh) * | 2022-09-29 | 2024-04-05 | 安徽皓元药业有限公司 | 一种非苏拉赞盐酸盐晶型a及其制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005511613A (ja) | 2001-11-08 | 2005-04-28 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 疾患治療用アザビシクロ置換ヘテロアリール化合物 |
| US7186716B2 (en) | 2002-08-12 | 2007-03-06 | Sugen, Inc. | 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
| ES2534605T3 (es) | 2004-08-23 | 2015-04-24 | Eli Lilly And Company | Agentes receptores de la histamina H3, preparación y usos terapéuticos |
| US7662832B2 (en) | 2004-09-03 | 2010-02-16 | Yuhan Corporation | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| ES2643615T3 (es) | 2004-09-30 | 2017-11-23 | F. Hoffmann-La Roche Ag | Composiciones y métodos para el tratamiento de trastornos cognitivos |
| WO2006036024A1 (ja) | 2004-09-30 | 2006-04-06 | Takeda Pharmaceutical Company Limited | プロトンポンプ阻害薬 |
| PL1919865T3 (pl) * | 2005-08-30 | 2011-09-30 | Takeda Pharmaceuticals Co | 1-heterocyklilosulfonylo, 2-aminometylo, 5-(hetero-) arylo podstawione pochodne 1-h-pirolu jako kwasowe inhibitory wydzielania |
| DE102005041246A1 (de) | 2005-08-31 | 2007-03-08 | Basf Coatings Ag | Von Molybän- und Wolframverbindungen freie, Cäsiumverbindungen enthaltende, härtbare Gemische auf der Basis blockierter Polyisocyanate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| BRPI0620081B8 (pt) | 2005-12-19 | 2021-05-25 | Pfizer | composto e composição farmacêutica. |
| JP2010501471A (ja) | 2006-05-04 | 2010-01-21 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | 衝動調節障害を処置するためのムスカリン様アゴニスト |
| DE102006027229A1 (de) * | 2006-06-09 | 2007-12-20 | Grünenthal GmbH | 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| US8933105B2 (en) * | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| WO2008131779A1 (en) | 2007-04-26 | 2008-11-06 | H. Lundbeck A/S | Isoquinolinone derivatives as nk3 antagonists |
| EP2560676B8 (en) | 2010-04-22 | 2016-10-12 | Intra-Cellular Therapies, Inc. | Organic compounds |
| AU2013347383B2 (en) * | 2012-11-19 | 2017-04-06 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof |
| TW201446761A (zh) | 2013-03-15 | 2014-12-16 | Acadia Pharm Inc | 蕈毒鹼（ｍｕｓｃａｒｉｎｉｃ）激動劑 |
| ITBS20130175A1 (it) | 2013-11-22 | 2015-05-23 | Ind Saleri Italo Spa | Gruppo pompa di raffreddamento regolabile con girante regolabile |
| WO2015134539A1 (en) | 2014-03-03 | 2015-09-11 | The Regents Of The University Of California | Mcl-1 antagonists |
| CN104447191B (zh) | 2014-10-30 | 2016-03-23 | 绵阳达高特新材料有限公司 | 4-溴-1,2-二氢环丁烯并[α]萘化合物及其制备方法 |
| CN104447491B (zh) * | 2014-11-19 | 2017-06-23 | 连云港恒运医药有限公司 | 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途 |
-
2016
- 2016-02-03 KR KR1020160013588A patent/KR101613245B1/ko active IP Right Grant
- 2016-04-08 KR KR1020160043522A patent/KR101818704B1/ko active IP Right Grant
- 2016-04-27 RU RU2017133866A patent/RU2663895C1/ru active
- 2016-04-27 HU HUE16786741A patent/HUE042449T2/hu unknown
- 2016-04-27 CA CA2977750A patent/CA2977750C/en active Active
- 2016-04-27 SG SG11201706877RA patent/SG11201706877RA/en unknown
- 2016-04-27 EP EP16786741.5A patent/EP3197867B1/en active Active
- 2016-04-27 MY MYPI2017703532A patent/MY193257A/en unknown
- 2016-04-27 SI SI201630148T patent/SI3197867T1/sl unknown
- 2016-04-27 MX MX2017012507A patent/MX2017012507A/es active IP Right Grant
- 2016-04-27 JP JP2017531371A patent/JP6244498B1/ja active Active
- 2016-04-27 AU AU2016255308A patent/AU2016255308B2/en active Active
- 2016-04-27 ES ES16786741T patent/ES2703709T3/es active Active
- 2016-04-27 PT PT16786741T patent/PT3197867T/pt unknown
- 2016-04-27 WO PCT/KR2016/004411 patent/WO2016175555A2/en active Application Filing
- 2016-04-27 US US15/520,518 patent/US10100010B1/en active Active
- 2016-04-27 NZ NZ734896A patent/NZ734896A/en unknown
- 2016-04-27 PE PE2017001632A patent/PE20180022A1/es unknown
- 2016-04-27 PL PL16786741T patent/PL3197867T3/pl unknown
- 2016-04-27 RS RS20181555A patent/RS58076B1/sr unknown
- 2016-04-27 CN CN201680003652.8A patent/CN107001263B/zh active Active
- 2016-04-27 TN TNP/2017/000424A patent/TN2017000424A1/en unknown
- 2016-04-27 MA MA40887A patent/MA40887B1/fr unknown
-
2017
- 2017-09-25 PH PH12017501755A patent/PH12017501755A1/en unknown
- 2017-10-03 DO DO2017000230A patent/DOP2017000230A/es unknown
- 2017-10-10 SA SA517390127A patent/SA517390127B1/ar unknown
- 2017-10-11 CL CL2017002571A patent/CL2017002571A1/es unknown
- 2017-10-13 CO CONC2017/0010539A patent/CO2017010539A2/es unknown
- 2017-10-25 EC ECIEPI201771036A patent/ECSP17071036A/es unknown
-
2018
- 2018-12-06 HR HRP20182066TT patent/HRP20182066T1/hr unknown
-
2021
- 2021-10-18 DO DO2021000213A patent/DOP2021000213A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182066T1 (hr) | Novi derivati 4-metoksi pirola ili njihove soli i farmaceutski pripravak koji ih sadrži | |
| IL265360B (en) | Pharmaceutical composition | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| IL265260B (en) | pharmaceutical preparations | |
| IL271986A (en) | pharmaceutical preparation | |
| IL253538B (en) | Heterocyclic compound and pharmaceutical compound containing it | |
| IL262654A (en) | Pharmacy preparation | |
| HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201712159D0 (en) | Pharmaceutical composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| EP2989093A4 (en) | Novel triazole derivatives or salts thereof and pharmaceutical composition therefor | |
| EP3328368A4 (en) | COMPOUNDS AND PHARMACEUTICAL COMPOSITION ASSOCIATED WITH UBIQUITINATION-PROTEASOME SYSTEM | |
| GB201719447D0 (en) | Pharmaceutical composition | |
| IL272419A (en) | Pharmaceutical composition | |
| EP3448839A4 (en) | CHINAZOLINE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| IL257621B (en) | A catechol derivative and a pharmaceutical preparation that includes it | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| PL3262047T3 (pl) | Pochodne imidazopirymidyny i imidazotriazyny i kompozycje farmaceutyczne je zawierające | |
| IL265436B (en) | Pharmacy preparation | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| IL265428A (en) | Pharmaceutical composition |